Skip to main content
Top
Published in: Cancer Causes & Control 4-5/2018

01-05-2018 | Original paper

An update in international trends in incidence rates of thyroid cancer, 1973–2007

Authors: Benjamin C. James, Janeil M. Mitchell, Heedo D. Jeon, Nektarios Vasilottos, Raymon H. Grogan, Briseis Aschebrook-Kilfoy

Published in: Cancer Causes & Control | Issue 4-5/2018

Login to get access

Abstract

Purpose

Over the past several decades, there has been a reported increase in the incidence of thyroid cancer in many countries. We previously reported an increase in thyroid cancer incidence across continents between 1973 and 2002. Here, we provide an update on the international trends in thyroid cancer between 2003 and 2007.

Methods

We examined thyroid cancer incidence data from the Cancer Incidence in Five Continents (CI5) database for the period between 1973 and 2007 from 24 populations in the Americas, Asia, Europe, Africa and Oceania, and report on the time trends as well as the distribution by histologic type and gender worldwide.

Results

The incidence of thyroid cancer increased during the period from 1998–2002 to 2003–2007 in the majority of populations examined, with the highest rates observed among women, most notably in Israel and the United States SEER registry, at over 14 per 100,000 people. This update suggests that incidence is rising in a similar fashion across all regions of the world. The histologic and gender distributions in the updated CI5 are consistent with the previous report.

Conclusions

Our analysis of the published CI5 data illustrates that the incidence of thyroid cancer increased between 1998–2002 and 2003–2007 in most populations worldwide, and rising rates continue in all regions of the world.
Literature
1.
go back to reference Forman D, Bray F, Brewster D, Gombe Mbalawa C, Kohler B, Pineros M, Steliarova-Focher E, Swaminathan R, Ferlay J (2014) Cancer Incidence in Fve Continents vol X. No. 164. IARC Scientific Publications, Lyon Forman D, Bray F, Brewster D, Gombe Mbalawa C, Kohler B, Pineros M, Steliarova-Focher E, Swaminathan R, Ferlay J (2014) Cancer Incidence in Fve Continents vol X. No. 164. IARC Scientific Publications, Lyon
2.
go back to reference Ahn H, Kim H, Welch G (2014) Korea’s thyroid-cancer “epidemic”—screening and over diagnosis. N Engl J Med 371:1765–1776CrossRefPubMed Ahn H, Kim H, Welch G (2014) Korea’s thyroid-cancer “epidemic”—screening and over diagnosis. N Engl J Med 371:1765–1776CrossRefPubMed
4.
go back to reference Bann DV, Goyal N, Camacho F, Goldenberg D (2014) Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania. JAMA Otolaryngol Head Neck Surg 140(12):1149–1156CrossRefPubMedPubMedCentral Bann DV, Goyal N, Camacho F, Goldenberg D (2014) Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania. JAMA Otolaryngol Head Neck Surg 140(12):1149–1156CrossRefPubMedPubMedCentral
5.
go back to reference Ramirez-Vick M, Nieves-Rodriguez M, Lugaro-Gomez A, Perez-Irizarry J (2011) Increasing incidence of thyroid cancer in Puerto Rico 1985–2004. P R Health Sci J 30(3):109–115PubMed Ramirez-Vick M, Nieves-Rodriguez M, Lugaro-Gomez A, Perez-Irizarry J (2011) Increasing incidence of thyroid cancer in Puerto Rico 1985–2004. P R Health Sci J 30(3):109–115PubMed
6.
go back to reference Amphlett B, Lawson Z, Abdulrahman GO Jr, White C, Bailey R, Premawardhana L, Okosieme OE (2013) Recent trends in the incidence geographical distribution and survival from thyroid cancer in Wales 1985–2010. Thyroid 23(11):1470–1478CrossRefPubMed Amphlett B, Lawson Z, Abdulrahman GO Jr, White C, Bailey R, Premawardhana L, Okosieme OE (2013) Recent trends in the incidence geographical distribution and survival from thyroid cancer in Wales 1985–2010. Thyroid 23(11):1470–1478CrossRefPubMed
7.
go back to reference Pazaitou-Panayiotou K, Iliadou P, Chrisoulidou A, Mitsakis P, Doumala E, Fotareli A, Boudina M, Mathiopoulou L, Patakiouta F, Tziomalos K (2013) The increase in thyroid cancer incidence is not only due to papillary microcarcinomas: a 40-year study in 1 778 patients. Exp Clin Endocrinol Diabetes 121(7):397–401CrossRefPubMed Pazaitou-Panayiotou K, Iliadou P, Chrisoulidou A, Mitsakis P, Doumala E, Fotareli A, Boudina M, Mathiopoulou L, Patakiouta F, Tziomalos K (2013) The increase in thyroid cancer incidence is not only due to papillary microcarcinomas: a 40-year study in 1 778 patients. Exp Clin Endocrinol Diabetes 121(7):397–401CrossRefPubMed
8.
go back to reference Xie S, Chen J, Zhang B, Wang F, Li S, Xie C, Tse L, Cheng J (2014) Time trends and age-period-cohort analyses on incidence rates of thyroid cancer in Shanghai and Hong Kong. BMC Cancer 14:975CrossRefPubMedPubMedCentral Xie S, Chen J, Zhang B, Wang F, Li S, Xie C, Tse L, Cheng J (2014) Time trends and age-period-cohort analyses on incidence rates of thyroid cancer in Shanghai and Hong Kong. BMC Cancer 14:975CrossRefPubMedPubMedCentral
9.
go back to reference Sokouti M, Montazeri V, Fakhrjou A, Samankan S, Goldust M (2013) Thyroid cancer clinical and histopathological study on patients under 25 years in Tabriz Iran (2000–2012). Pak J Biol Sci 16(24):2003–2008CrossRefPubMed Sokouti M, Montazeri V, Fakhrjou A, Samankan S, Goldust M (2013) Thyroid cancer clinical and histopathological study on patients under 25 years in Tabriz Iran (2000–2012). Pak J Biol Sci 16(24):2003–2008CrossRefPubMed
10.
go back to reference Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N, Zhang Y (2009) International patterns and trends in thyroid cancer incidence 1973–2002. Cancer Causes Control 20(5):525–531CrossRefPubMed Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N, Zhang Y (2009) International patterns and trends in thyroid cancer incidence 1973–2002. Cancer Causes Control 20(5):525–531CrossRefPubMed
11.
go back to reference Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol
12.
go back to reference Burgess JR. Skabo S, McArdle K, Tucker P (2002) Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid 12(2):141–149CrossRefPubMed Burgess JR. Skabo S, McArdle K, Tucker P (2002) Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid 12(2):141–149CrossRefPubMed
13.
go back to reference Leenhardt L, Grosclaude P, Chérié-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14(12):1056–1060CrossRefPubMed Leenhardt L, Grosclaude P, Chérié-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14(12):1056–1060CrossRefPubMed
14.
go back to reference Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317(13):1338–1348CrossRefPubMed Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317(13):1338–1348CrossRefPubMed
15.
go back to reference Londero SC, Krogdahl A, Bastholt L, Overgaard J, Pedersen HB, Frisch T, Bentzen J, Pedersen PU, Christiansen P, Godballe C (2010) Papillary thyroid carcinoma in Denmark 1996–2008: an investigation of changes in incidence. Am J Surg 200(4):462–466CrossRef Londero SC, Krogdahl A, Bastholt L, Overgaard J, Pedersen HB, Frisch T, Bentzen J, Pedersen PU, Christiansen P, Godballe C (2010) Papillary thyroid carcinoma in Denmark 1996–2008: an investigation of changes in incidence. Am J Surg 200(4):462–466CrossRef
16.
go back to reference Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (2007) Cancer Incidence in Five Continents vol IX No 160. IARC Scientific Publications, Lyon Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (2007) Cancer Incidence in Five Continents vol IX No 160. IARC Scientific Publications, Lyon
17.
go back to reference Parkin DM, Whelan SL, Ferlay J, Storm H (2005) Cancer Incidence in Five Continents vol I to VIII No 7. IARC CancerBase, Lyon Parkin DM, Whelan SL, Ferlay J, Storm H (2005) Cancer Incidence in Five Continents vol I to VIII No 7. IARC CancerBase, Lyon
18.
go back to reference WHO Cancer Mortality Database (2016) World Health Organization International Agency for Research on Cancer. Accessed 16 December 2016 WHO Cancer Mortality Database (2016) World Health Organization International Agency for Research on Cancer. Accessed 16 December 2016
19.
go back to reference Verkooijen H, Fioretta G, Pache J, Franceschi S, Raymond L, Schubert H, Bouchardy C (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14(1):13–17CrossRefPubMed Verkooijen H, Fioretta G, Pache J, Franceschi S, Raymond L, Schubert H, Bouchardy C (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14(1):13–17CrossRefPubMed
20.
go back to reference Montanaro F, Pury P, Bordoni A, Lutz JM, Swiss Cancer Registries Network (2006) Unexpected additional increase in the incidence of thyroid cancer among a recent birth cohort in Switzerland. Eur J Cancer Prev 15(2):178–186CrossRefPubMed Montanaro F, Pury P, Bordoni A, Lutz JM, Swiss Cancer Registries Network (2006) Unexpected additional increase in the incidence of thyroid cancer among a recent birth cohort in Switzerland. Eur J Cancer Prev 15(2):178–186CrossRefPubMed
21.
go back to reference Aschebrook-Kilfoy B, DellaValle C, Purdue M, Kim C, Zhang Y, Sjodin A, Ward M (2015) Polybrominated diphenyl ethers and thyroid cancer risk in the prostate colorectal lung and ovarian cancer screening trial cohort. Am J Epidemiol 181(11):883–888CrossRefPubMedPubMedCentral Aschebrook-Kilfoy B, DellaValle C, Purdue M, Kim C, Zhang Y, Sjodin A, Ward M (2015) Polybrominated diphenyl ethers and thyroid cancer risk in the prostate colorectal lung and ovarian cancer screening trial cohort. Am J Epidemiol 181(11):883–888CrossRefPubMedPubMedCentral
22.
go back to reference Zeng Q, Chen CG, Vlantis A, van Hasselt C (2007) Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif 40(6):921–935CrossRefPubMed Zeng Q, Chen CG, Vlantis A, van Hasselt C (2007) Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif 40(6):921–935CrossRefPubMed
23.
go back to reference Chen G, Vlantis A, Zeng Q, van Hasselt C (2008) Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets 8(5):367–377CrossRefPubMed Chen G, Vlantis A, Zeng Q, van Hasselt C (2008) Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets 8(5):367–377CrossRefPubMed
24.
go back to reference Kumar A, Klinge C, Goldstein R (2010) Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Int J Oncol 36(5):1067–1080PubMed Kumar A, Klinge C, Goldstein R (2010) Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Int J Oncol 36(5):1067–1080PubMed
25.
go back to reference Rajoria S, Suriano R, Shanmugam A, Wilson Y, Schantz SP, Geliebter J, Tiwari R (2010) Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 20(1):33–41CrossRefPubMedPubMedCentral Rajoria S, Suriano R, Shanmugam A, Wilson Y, Schantz SP, Geliebter J, Tiwari R (2010) Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 20(1):33–41CrossRefPubMedPubMedCentral
26.
go back to reference Derwahl M, Nicula D (2014) Estrogen and its role in thyroid cancer. Endocr Relat Cancer 21(5):T273–T283CrossRefPubMed Derwahl M, Nicula D (2014) Estrogen and its role in thyroid cancer. Endocr Relat Cancer 21(5):T273–T283CrossRefPubMed
27.
go back to reference Shindo H, Amino N, Ito Y, Kihara M, Kobayashi K, Miya A, Hirokawa M, MIyauchi A (2014) Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid 24(5):840–844CrossRefPubMed Shindo H, Amino N, Ito Y, Kihara M, Kobayashi K, Miya A, Hirokawa M, MIyauchi A (2014) Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid 24(5):840–844CrossRefPubMed
28.
go back to reference Messuti I, Corvisieri S, Bardesono F, Rapa I, Giorcelli J, Pellerito R, Volante M, Orlandi F (2014) Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features. Eur J Endocrinol 170(5):659–666CrossRefPubMed Messuti I, Corvisieri S, Bardesono F, Rapa I, Giorcelli J, Pellerito R, Volante M, Orlandi F (2014) Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features. Eur J Endocrinol 170(5):659–666CrossRefPubMed
Metadata
Title
An update in international trends in incidence rates of thyroid cancer, 1973–2007
Authors
Benjamin C. James
Janeil M. Mitchell
Heedo D. Jeon
Nektarios Vasilottos
Raymon H. Grogan
Briseis Aschebrook-Kilfoy
Publication date
01-05-2018
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 4-5/2018
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1023-2

Other articles of this Issue 4-5/2018

Cancer Causes & Control 4-5/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine